CODX vs TFC
Co-Diagnostics, Inc. Common Stock (CODX) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
TFC (TFC) common stock.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
CODX currently screens at market cap $31.4M. TFC currently screens at market cap $0.
Not investment advice. Open the CODX and TFC stock pages for the full models.
Not investment advice.